Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Intelligent Bio Solutions Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 533.7K | 415.2K | −118.5K (−22.2%) |
| Value | $416.0K | $272.0K | −$144.0K (−34.6%) |
New holders (4)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 33,695 | $22.0K | 0.00% |
| HRT Financial LP | 20,568 | $13.0K | 0.00% |
| Vanguard Group Inc | 16,454 | $11.0K | 0.00% |
| Ergoteles LLC | 14,200 | $9.00K | 0.00% |
Sold out (5)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Bridgeway Capital Management, LLC | 50,000 | $39.0K |
| Goldman Sachs Group Inc | 42,800 | $33.0K |
| BlackRock Inc. | 31,174 | $24.0K |
| Citadel Advisors LLC | 29,422 | $23.0K |
| Tower Research Capital LLC (TRC) | 3,918 | $3.00K |